David R. Bauer
Lawyers
Filters
GSK $3.3 billion acquisition of Affinivax
We are advising GSK on the acquisition
PayPal $3 billion notes offering and concurrent tender offer
The investment-grade notes were issued in four tranches
Bausch + Lomb $630 million IPO
We are advising Bausch Health on the separation of its eye health business into a new public company, Bausch + Lomb
Qualcomm $1.5 billion notes offering
The investment-grade notes are due 2032 and 2052
SiTime at-the-market offering
The stock offering is SEC-registered
Deciphera Pharmaceuticals $172.5 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
HilleVax $200 million IPO
The shares are listed on the Nasdaq Global Select Market
Acutus Medical sale of its left-heart access portfolio products
We are advising Acutus Medical on the transaction
Natus Medical $1.2 billion acquisition by ArchiMed
We are advising Natus Medical on the transaction
Charles River Laboratories $295 million acquisition of Explora BioLabs Holdings
We advised Charles River on the transaction